PharmGen Science, Inc. (KOSE: A004720)
Health Care · Pharmaceuticals · KR
₩2,850.00
+0.88% today · -32.1% 1Y
PharmGen Science, Inc. (KOSE: A004720) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $47.85M.
Over the last twelve months the share price has lost 32.1%, trading between 2.59K and 4.49K.
Tweenvest scores PharmGen Science, Inc. across four factors: quality 75/100, value 45/100. Its strongest factor is quality.
A004720 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $47.85M
- Revenue (TTM)
- $116.56M
- P/E
- —
- EPS
- 6.50
- Dividend yield
- —
- Beta (5Y)
- 0.38
- 52-week high
- ₩4,485.00
- 52-week low
- ₩2,590.00
- Avg volume (3M)
- —
- Shares outstanding
- 22.61M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| China NT Pharma Group Company LimitedSEHK: 1011 | $49.58M | HK$0.41 | +6.49% |
| AB Science S.A.ENXTPA: AB | $48.99M | €0.54 | -0.74% |
| BioStem Technologies, Inc.NasdaqCM: BSEM | $48.73M | $2.73 | -34.06% |
| GL Pharm Tech Corp.KOSDAQ: A204840 | $48.37M | ₩4,200.00 | -2.78% |
| Haleos Labs LimitedNSEI: HALEOSLABS | $46.79M | Rs1,490.00 | -0.79% |
| Trident Lifeline LimitedBSE: 543616 | $46.64M | Rs376.35 | -7.69% |
| Orexo AB (publ)OM: ORX | $46.63M | Skr7.00 | -47.76% |
| Decibel Cannabis Company Inc.TSXV: DB | $46.40M | CA$1.72 | -3.37% |
Figures last refreshed Oct 4, 2026.